Corona Remedies (NSE:CORONA) Interest Expense: ₹-57 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CORONA Corona Remedies Ltd NSE:CORONA
18 GF Score
Price ₹2,058.80
! 4 Warning Signs
View Full Analysis

What is Corona Remedies Interest Expense?

Corona Remedies NSE:CORONA +0.65% 18 Interest Expense is ₹-57 Mil as of Jun. 2026. GuruFocus rates NSE:CORONA with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Corona Remedies's interest expense for the three months ended in Jun. 2026 was ₹ -27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-57 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Corona Remedies's Operating Income for the three months ended in Jun. 2026 was ₹ 799 Mil. Corona Remedies's Interest Expense for the three months ended in Jun. 2026 was ₹ -27 Mil. Corona Remedies's Interest Coverage for the quarter that ended in Jun. 2026 was 29.70. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Corona Remedies  (NSE:CORONA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Corona Remedies's Interest Expense for the three months ended in Jun. 2026 was ₹-27 Mil. Its Operating Income for the three months ended in Jun. 2026 was ₹799 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was ₹0 Mil.

Corona Remedies's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*798.9/-26.9
=29.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Corona Remedies Interest Expense Historical Data

* Premium members only.

The historical data trend for Corona Remedies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corona Remedies Interest Expense Chart

Corona Remedies Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Interest Expense
-23.85 -114.95 -80.40 -45.70

Corona Remedies Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial -22.00 -19.90 -16.60 -13.80 -26.90
NSE:CORONA
18GF Score
Corona Remedies Ltd NSE:CORONA
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corona Remedies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-57 Mil mean?
Corona Remedies (NSE:CORONA) has a Interest Expense of ₹-57 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Corona Remedies and its competitors.
Is Corona Remedies' Interest Expense too high?
Corona Remedies' current Interest Expense is ₹-57 Mil. Overall, Corona Remedies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Corona Remedies' Interest Expense compare to LLY and JNJ?
Corona Remedies' Interest Expense of ₹-57 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Corona Remedies and its competitors. Corona Remedies's current Interest Expense is ₹-57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corona Remedies stock overvalued right now?
Corona Remedies (NSE:CORONA) has a current Interest Expense of ₹-57 Mil. The current Interest Expense is ₹-57 Mil. Corona Remedies' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Corona Remedies (NSE:CORONA), the current Interest Expense is ₹-57 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corona Remedies Business Description

Other Exchanges 544644:India
Address S. G. Highway, CORONA House, C - Mondeal Business Park, Near Gurudwara, Thaltej, Ahmedabad, GJ, IND, 380 059
Corona Remedies Ltd is mainly engaged in the business of manufacturing, trading and marketing of Pharmaceutical products. It is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other segments, such as Vitamin Minerals and Nutrients(VMN), gastrointestinal and respiratory therapies. The company's brands are B-29, myoril, Tricium, Cortel, and Obimet. The Company has only one reportable business segment i.e. Pharmaceuticals. The company has presence in India as well as Outside India. The company generates majority of revenue from India.
18GF Score

Get the complete analysis for NSE:CORONA

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,058.80
Price